Wanbury Limited — Updates, 20-05-2025: Press Release
20-05-2025 | 08:54 am
20-05-2025 | 08:54 am
Wanbury Limited has announced a board meeting to approve the financial results for the quarter and half-year. Its Patalganga manufacturing facility received the GMP certificate from Brazil's ANVISA, making both API sites compliant with Brazilian standards. This certification enhances Wanbury’s export potential and strengthens its foothold in the regulated Brazilian pharmaceutical market and Latin America. No financial impact was disclosed.
No comments yet. Be the first to comment!
